FDA Approves Oral Daprodustat to Treat Anemia in Dialysis
The FDA approval of daprodustat is based on results from the ASCEND-D trial comparing daprodustat with ESAs.
The FDA approval of daprodustat is based on results from the ASCEND-D trial comparing daprodustat with ESAs.
In both men and women, the prevalence of severe anemia increased as kidney function decreased.
Patients with anemia may know some of the risks associated with the condition, but do they know about potential cancer-related risks? How can health care professionals educate patients on the risks, and what is known about the potential association between newly diagnosed anemia and cancer risk?
Investigators report results from a systematic review and meta-analysis of data from 23 randomized controlled trials involving 15,144 patients with anemia of CKD.
According to investigators, it is crucial to find the underlying causes of post-transplant anemia and to treat all reversible causes.
For each additional needle pass during the kidney biopsy, the likelihood of major complications increased 22%, investigators found.
The benefits of treating anemia may need to be balanced against the risk of developing infection, according to investigators.
Receipt of any RBC transfusion was significantly associated with increased risk for venous thromboembolism.
Blood urea nitrogen (BUN) in NDD-CKD represents nitrogenous uremic toxin accumulation that could be involved in anemia of CKD.
Lead in municipal drinking water, even at levels allowed by the EPA, are associated with lower hemoglobin levels in patients with advanced chronic kidney disease, a study found.